Among the new strategies in the efforts of treating malignant tumours expressing different growth factors, and more specifically IGF-I, TGF beta, VEGF, or EGF [3, 6, 35, 37], the anti-gene therapy approach, either antisense or triple helix, appears as a promising solution [39]. This evidence concerns the gene IGF1 and cancer.